Poland
· Delayed Price · Currency is PLN Medinice Company Description
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery.
The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technology that uses liquid nitrogen as the cooling medium; and AtriClamp, a clip designed to close the left atrial appendage to minimize the risk of stroke in patients with atrial fibrillation.
It also provides MiniMax, an ablation-mapping catheter used for detecting intracardiac electrophysiological signals, creating a 3D map of the heart, and performing intracardiac irrigated RF ablation to treat arrhythmias caused by abnormalities in the heart’s conduction system; and EP Bioptom, an electrode for endomyocardial biopsy using 3D mapping enabling simultaneous biopsy and creation of a three-dimensional heart map.
The company was founded in 2012 and is headquartered in Warsaw, Poland.
| Country | Poland |
| Founded | 2012 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Sanjeev Choudhary |
Contact Details
Address: Hankiewicza St. 2 Warsaw, 02-103 Poland | |
| Phone | 48 725 50 00 51 |
| Website | medinice.pl |
Stock Details
| Ticker Symbol | ICE |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLMDNCE00016 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Sanjeev Choudhary | President of the Management Board and Chief Executive Officer |